Institutional investors purchased a net $104.1 thousand shares of PBYI during the quarter ended June 2015. This may signal that the smart money is gaining interest in this company as the 95.25% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
GRANTHAM, MAYO, VAN OTTERLOO & C... Bought 1.4 Million shares of Puma Biotechnology Inc
CAPITAL RESEARCH & MANAGEMENT CO... Bought 591.6 Thousand shares of Puma Biotechnology Inc